Study flags over-reliance on computer tests in return-to-plan decisions after concussion
February 2, 2012 in NeuroscienceA new study by researchers at Indiana University-Purdue University Columbus and Pace University is critical of the widespread use of computerized neuropsychological tests (CNT) in decisions regarding when athletes can return to play after suffering a concussion.
"Our knowledge of the effects of concussions continues to evolve," said Thomas Redick, assistant professor of psychology at IUPUC. "We should continue to ask ourselves what the best practices are when dealing with a brain injury, which is what a concussion is."
The use of computer tests to measure an athlete's thinking ability before and after concussion has become commonplace at all levels of contact sport, typically beginning in high school, and the post-trauma test result is one part in determining when an athlete can get back in the game. The dangers of returning to play prematurely can be grave -- including the rare cases that lead to a degeneration of brain tissue (chronic traumatic encephalopathy) and even death. Yet the ability to determine the severity of a head trauma and stage of recovery is very difficult.
"We should note that no 'gold standard' exists for concussion diagnosis and management," the researchers wrote. "Sports medicine practitioners still lack simple, reliable and affordable techniques to confidently address these issues. Although experienced first responders can accomplish a clinical diagnosis in most instances of suspected concussion, concerns related to return of play and whether or not to continue specific sport participation are not resolved by current CNT."
The study, published online in the Journal of Clinical and Experimental Neuropsychology, reviewed previously published research articles involving Immediate Post-concussion Assessment and Cognitive Testing (ImPACT), one of several CNT in use today and considered the most scientifically validated computerized concussion evaluation system. The researchers cautioned against over-reliance on CNT in return-to-play decisions for the following reasons:
- The tests, which are often measured in the preseason as a baseline and then again after a concussion, may not possess adequate levels of reliability to use in the management of individual athletes. This could lead injured athletes to return to play before being fully recovered. In contrast, low test reliability could keep athletes out of further contests longer than necessary, which can have adverse effects for the team and the athlete.
- The tests do not measure other important aspects of brain function, such as functional and metabolic impairments of the brain. Tests using other techniques have revealed abnormal brain function for up to 28 days after the injury. Studies have indicated that ImPACT cognitive performance typically normalizes within three weeks of the injury. "Postconcussion cognition recovery appears to occur relatively quickly, but this does not equate to rapid healing of an injured brain," the researchers wrote in the research article.
- The only treatment for concussions is physical and cognitive rest. Taking a 20-minute detailed test in order to confirm a clinically apparent concussion could harm recovery.
- Future research with ImPACT and other CNT is warranted to provide the most accurate and reliable information possible about the cognitive state of athletes after suffering a concussion.
More information: "Clinical utility of ImPACT assessment for postconcussion return-to-play counseling: Psychometric issues," will appear in the Journal of Clinical and Experimental Neuropsychology in mid-February. The co-author is Lester B. Mayers, M.D., Division of Sports Medicine, Pace University.
Provided by
Indiana University
-
Does baseline concussion testing really reduce risks to athletes?
Jun 01, 2011 |
not rated yet |
0
-
Simple test may help judge concussion in athletes
Feb 15, 2010 |
not rated yet |
0
-
Concussion testing makes everyone tired
Dec 06, 2011 |
not rated yet |
0
-
Concussed high school athletes who receive neuropsychological testing sidelined longer
Dec 15, 2010 |
not rated yet |
0
-
Concussions change brains
Nov 22, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
19 hours ago
-
Popping/Cracked sternum.
23 hours ago
-
Which Mental Illness Encompasses This Problem?
May 25, 2012
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Neuroscience
May 25, 2012 |
not rated yet |
0
|
Persistent sensory experience is good for aging brain
Despite a long-held scientific belief that much of the wiring of the brain is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. ...
Neuroscience
May 24, 2012 |
not rated yet |
0
Boundary stops molecule right where it needs to be
A molecule responsible for the proper formation of a key portion of the nervous system finds its way to the proper place not because it is actively recruited, but instead because it can't go anywhere else.
Neuroscience
May 24, 2012 |
not rated yet |
0
|
Locating ground zero: How the brain's emergency workers find the disaster area
Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. ...
Neuroscience
May 24, 2012 |
5 / 5 (2) |
0
|
Genetic 'reset switch' enables signaling pathway to induce multiple developmental outcomes for olfactory neurons
Within the nervous system, a handful of signaling pathways modulate development of a cornucopia of different neuronal subtypes. Even small alterations in neuron differentiation pathways can disrupt subsequent ...
Neuroscience
May 24, 2012 |
not rated yet |
0
Keep food safety in mind this memorial day weekend
(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.